Stephen M Kerr1, Samantha E Parker2, Allen A Mitchell1, Sarah C Tinker3, Martha M Werler4. 1. Slone Epidemiology Center at Boston University, Boston, MA. 2. Slone Epidemiology Center at Boston University, Boston, MA; Department of Epidemiology, Boston University, Boston, MA. Electronic address: separker@bu.edu. 3. National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, GA. 4. Slone Epidemiology Center at Boston University, Boston, MA; Department of Epidemiology, Boston University, Boston, MA.
Abstract
PURPOSE: Previous studies have shown an association between maternal fever in early pregnancy and neural tube defects (NTDs) such as spina bifida. Periconceptional folic acid intake has been shown to reduce the risk of these outcomes. METHODS: Using data from the Slone Epidemiology Center Birth Defects Study (1998-2015), we examined the impact of folic acid on the relationship between maternal fever in the periconceptional period (28 days before and after the last menstrual period) and NTDs. Logistic regression models were used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Mothers of 375 cases and 8247 nonmalformed controls were included. We observed an elevated risk for NTDs for fever in the periconceptional period (OR: 2.4; 95% CI: 1.5-4.0). This association was weaker for mothers who reported consuming the recommended amount of folic acid (≥400 μg per day; OR: 1.8; 95% CI: 0.8-4.0) than mothers with low folic acid intake (<400 μg per day; OR: 4.2; 95% CI: 2.2-8.2). CONCLUSIONS: Our data support an association between maternal periconceptional fever and an increased risk for NTDs and also provide evidence that this association was attenuated for mothers who reported consuming folic acid at recommended levels in the periconceptional period.
PURPOSE: Previous studies have shown an association between maternal fever in early pregnancy and neural tube defects (NTDs) such as spina bifida. Periconceptional folic acid intake has been shown to reduce the risk of these outcomes. METHODS: Using data from the Slone Epidemiology Center Birth Defects Study (1998-2015), we examined the impact of folic acid on the relationship between maternal fever in the periconceptional period (28 days before and after the last menstrual period) and NTDs. Logistic regression models were used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Mothers of 375 cases and 8247 nonmalformed controls were included. We observed an elevated risk for NTDs for fever in the periconceptional period (OR: 2.4; 95% CI: 1.5-4.0). This association was weaker for mothers who reported consuming the recommended amount of folic acid (≥400 μg per day; OR: 1.8; 95% CI: 0.8-4.0) than mothers with low folic acid intake (<400 μg per day; OR: 4.2; 95% CI: 2.2-8.2). CONCLUSIONS: Our data support an association between maternal periconceptional fever and an increased risk for NTDs and also provide evidence that this association was attenuated for mothers who reported consuming folic acid at recommended levels in the periconceptional period.
Authors: Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell Journal: N Engl J Med Date: 2007-06-28 Impact factor: 91.245
Authors: Carol Louik; Stephen Kerr; Carla M Van Bennekom; Christina Chambers; Kenneth L Jones; Michael Schatz; Allen A Mitchell Journal: Vaccine Date: 2016-07-21 Impact factor: 3.641
Authors: Varsha Neelam; Emily L Reeves; Kate R Woodworth; Emily O'Malley Olsen; Megan R Reynolds; Joy Rende; Heather Wingate; Susan E Manning; Paul Romitti; Kristen D Ojo; Kristin Silcox; Jerusha Barton; Evan Mobley; Nicole D Longcore; Ayomide Sokale; Mamie Lush; Camille Delgado-Lopez; Abdoulaye Diedhiou; Deborah Mbotha; Wanda Simon; Bethany Reynolds; Tahani S Hamdan; Suzann Beauregard; Esther M Ellis; Jennifer Y Seo; Amanda Bennett; Sascha Ellington; Aron J Hall; Eduardo Azziz-Baumgartner; Van T Tong; Suzanne M Gilboa Journal: Birth Defects Res Date: 2022-09-06 Impact factor: 2.661
Authors: Marjan Mosalman Haghighi; Caradee Yael Wright; Julian Ayer; Michael F Urban; Minh Duc Pham; Melanie Boeckmann; Ashtyn Areal; Bianca Wernecke; Callum P Swift; Matthew Robinson; Robyn S Hetem; Matthew F Chersich Journal: Int J Environ Res Public Health Date: 2021-05-05 Impact factor: 3.390
Authors: Lisa M Bebell; Kathy Burgoine; Mercedeh Movassagh; Christine Hehnly; Lijun Zhang; Kim Moran; Kathryn Sheldon; Shamim A Sinnar; Edith Mbabazi-Kabachelor; Elias Kumbakumba; Joel Bazira; Moses Ochora; Ronnie Mulondo; Brian Kaaya Nsubuga; Andrew D Weeks; Melissa Gladstone; Peter Olupot-Olupot; Joseph Ngonzi; Drucilla J Roberts; Frederick A Meier; Rafael A Irizarry; James R Broach; Steven J Schiff; Joseph N Paulson Journal: NPJ Biofilms Microbiomes Date: 2021-09-10 Impact factor: 7.290
Authors: Richard H Finnell; Carlo Donato Caiaffa; Sung-Eun Kim; Yunping Lei; John Steele; Xuanye Cao; Gabriel Tukeman; Ying Linda Lin; Robert M Cabrera; Bogdan J Wlodarczyk Journal: Front Genet Date: 2021-05-10 Impact factor: 4.599